Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa.

Byfield FJ, Kowalski M, Cruz K, Leszczyńska K, Namiot A, Savage PB, Bucki R, Janmey PA.

J Immunol. 2011 Dec 15;187(12):6402-9. doi: 10.4049/jimmunol.1102185. Epub 2011 Nov 16.

2.

The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.

Méndez-Samperio P.

Peptides. 2010 Sep;31(9):1791-8. doi: 10.1016/j.peptides.2010.06.016. Epub 2010 Jun 25. Review.

PMID:
20600427
3.

Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide.

Golec M.

Ann Agric Environ Med. 2007;14(1):1-4. Review.

4.

Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells.

Niyonsaba F, Hirata M, Ogawa H, Nagaoka I.

Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):224-31. Review.

PMID:
14561157
5.

Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells.

van Wetering S, Tjabringa GS, Hiemstra PS.

J Leukoc Biol. 2005 Apr;77(4):444-50. Epub 2004 Dec 9. Review.

PMID:
15591123
6.

Cathelicidin LL-37: a multitask antimicrobial peptide.

Bucki R, Leszczyńska K, Namiot A, Sokołowski W.

Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):15-25. doi: 10.1007/s00005-009-0057-2. Epub 2010 Jan 5. Review.

PMID:
20049649
7.

The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.

Tjabringa GS, Rabe KF, Hiemstra PS.

Pulm Pharmacol Ther. 2005;18(5):321-7. Review.

PMID:
15939310
8.

Cathelicidins--a family of multifunctional antimicrobial peptides.

Bals R, Wilson JM.

Cell Mol Life Sci. 2003 Apr;60(4):711-20. Review.

PMID:
12785718
9.

Cathelicidins: a family of endogenous antimicrobial peptides.

Lehrer RI, Ganz T.

Curr Opin Hematol. 2002 Jan;9(1):18-22. Review.

PMID:
11753073
10.

A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

Vandamme D, Landuyt B, Luyten W, Schoofs L.

Cell Immunol. 2012 Nov;280(1):22-35. doi: 10.1016/j.cellimm.2012.11.009. Epub 2012 Nov 29. Review.

PMID:
23246832
11.

Unique features of human cathelicidin LL-37.

Bandurska K, Berdowska A, Barczyńska-Felusiak R, Krupa P.

Biofactors. 2015 Sep-Oct;41(5):289-300. doi: 10.1002/biof.1225. Epub 2015 Oct 5. Review.

PMID:
26434733
12.
13.

Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.

Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, Wu K, Yu J, Sung JJ, Cho CH.

Int J Cancer. 2010 Oct 15;127(8):1741-7. doi: 10.1002/ijc.25489. Review.

14.

The Role of Cathelicidin LL-37 in Cancer Development.

Piktel E, Niemirowicz K, Wnorowska U, Wątek M, Wollny T, Głuszek K, Góźdź S, Levental I, Bucki R.

Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):33-46. doi: 10.1007/s00005-015-0359-5. Epub 2015 Sep 22. Review.

15.

LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.

Fabisiak A, Murawska N, Fichna J.

Pharmacol Rep. 2016 Aug;68(4):802-8. doi: 10.1016/j.pharep.2016.03.015. Epub 2016 Apr 7. Review.

PMID:
27117377
16.

Molecular mechanisms of LL-37-induced receptor activation: An overview.

Verjans ET, Zels S, Luyten W, Landuyt B, Schoofs L.

Peptides. 2016 Nov;85:16-26. doi: 10.1016/j.peptides.2016.09.002. Epub 2016 Sep 5. Review.

PMID:
27609777

Supplemental Content

Support Center